Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon, shared on LinkedIn:

“Hot off the press! Work from Minoo Battiwalla et al on behalf of HCA Healthcare, Sarah Cannon Cancer. Network that highlights access barriers to CART therapies for lymphoma. Among patients who made it as a referral to a Sarah Cannon Transplant and Cellular Therapy Network CART center between 2018-2022, 40% did not make it to CART infusion. Emphasizes that a lot of work still needs to be done to enhance access to these transformative therapies.”

Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network | Blood Advances | American Society of Hematology

Authors: Minoo Battiwalla, Michael Tees, Ian Flinn, Jeremy Pantin, Jesus Berdeja, Tara Gregory, Michael Maris, Vikas Bhushan, Estil Vance, John Mathews, Carlos Bachier, Paul Shaughnessy, Aravind Ramakrishnan, Shahbaz Malik, Shahram Mori, Casey Martin, Rocky Billups, Betsy Blunk, Charles F. LeMaistre, Navneet S. Majhail

Navneet Majhail: Access barriers to anti-CD19+ CART therapies for lymphoma